Table 3 Pathologic outcomes.
Outcome | CL | TRA | P value | ||
|---|---|---|---|---|---|
Mean (SD) | (n = 59) | (n = 89) | |||
Lymph node yield | 15.00 | (7.21) | 14.64 | (7.95) | 0.78 |
Histology (%) | 0.52 | ||||
Low grade | 47 | (88.68) | 70 | (81.40) | |
High grade | 5 | (9.43) | 13 | (15.12) | |
CSM | 1 | (1.89) | 3 | (3.49) | |
LVSI (%) | 12 | (20.34) | 13 | (14.77) | 0.38 |
Stage (%) | 0.16 | ||||
IA | 49 | (83.05) | 70 | (78.65) | |
IB | 7 | (11.86) | 8 | (8.99) | |
II | 0 | (0.00) | 8 | (8.99) | |
IIIA | 2 | (3.39) | 1 | (1.12) | |
IIIC1 | 1 | (1.69) | 2 | (2.25) | |
Positive cytology (%) | 13 | (23.64) | 19 | (21.35) | 0.66 |
Adjuvant therapy (%) | 12 | (20.34) | 28 | (31.46) | 0.14 |
